Eli Lilly stock edges higher as company plans nearly $4 billion in vaccine deals
RSS SUMMARY · AGGREGATED FROM CNBC
The deals are part of Eli Lilly’s effort to expand into infectious disease research and development.
The deals are part of Eli Lilly’s effort to expand into infectious disease research and development.
The deals are part of Eli Lilly’s effort to expand into infectious disease research and development.
Continue Reading
The full story continues on CNBC.
Story Sentry shows a short summary aggregated via RSS. The complete article — original photography, charts, and reporting — lives with the publisher.
The Source
CNBC
US
Elon Musk’s net worth poised to sail past $1 trillion in SpaceX IPO
CNBC·1h ago·3 min read
US
Broadcom stock slips on disappointing software revenue
CNBC·4h ago·3 min read
US
Senate GOP strips up to $1B for Trump ballroom security from immigration enforcement bill
CNBC·5h ago·3 min read
Business
As Honeywell Aerospace readies for its standalone debut, its CEO is forecasting big growth
CNBC·5h ago·3 min read
Related
On this beat
US
NBA finals 2026 Game 1: New York Knicks v San Antonio Spurs – live
THE GUARDIAN·1h ago·3 min read
US
The Afghanistan-Pakistan Border Is Still Unstable
FP·1h ago·3 min read
US
Frontier passengers tackle man who allegedly choked off-duty flight attendant, tried to open door mid-flight
FOX NEWS·1h ago·3 min read
US
Israel and Lebanon agree on a full ceasefire, conditioned on steps by Hezbollah
AXIOS·1h ago·3 min read